The INFINITY study protocol: a retrospective cohort study on decision making and clinical impact of biomarker-driven precision oncology in routine clinical practice

BACKGROUND: Precision oncology, defined as treatment of patients with targeted therapies matched to specific molecular alterations, has entered routine clinical practice. Particularly in patients with advanced cancer or hematologic malignancies, for whom no further standard therapies are available,...

Descripción completa

Detalles Bibliográficos
Autores principales: Martens, Uwe M., Schröder, Jan, Bengsch, Fee, Sellmann, Ludger, Busies, Sabine, Frank-Gleich, Stefanie, Zaiss, Matthias, Decker, Thomas, Schneeweiss, Andreas, Schuler, Martin, Grebhardt, Sina, Zacharias, Stefan, Marschner, Norbert, Kasenda, Benjamin, Potthoff, Karin, Vannier, Corinne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265846/
https://www.ncbi.nlm.nih.gov/pubmed/37312086
http://dx.doi.org/10.1186/s12885-023-11046-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265846/
https://www.ncbi.nlm.nih.gov/pubmed/37312086
http://dx.doi.org/10.1186/s12885-023-11046-3

Ejemplares similares